Waldrop Jacob A. 4

What Happened

• Jacob A. Waldrop, Chief Operating Officer of Sanara MedTech, was granted 13,956 restricted shares (transaction code A) on 2026-03-22. The grant is reported at $0.00 per share (award/compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-22; Form 4 filed 2026-03-23 (timely).
• Shares granted: 13,956 restricted shares; reported price: $0.00.
• Transaction type: Award/Grant (code A) under the Sanara MedTech 2024 Omnibus Long-Term Incentive Plan.
• Vesting: One-third vests on March 22 of 2027, 2028 and 2029, subject to continued employment (see footnote F1).
• Shares owned after the transaction: Not specified in the provided filing details.
• Filing accession: 0001493152-26-012181.

Context

• This is a compensation award (restricted stock) that vests over time and depends on continued employment; it is not an immediate market buy or sell. Such awards are common executive compensation and do not by themselves indicate insider buying or selling intent until/if shares vest and are sold.